There are big variations in care for people receiving orthopedic services in the NHS – orthopedics covers conditions involving the musculoskeletal system including hip and knee replacement surgery. We are evaluating the Getting it Right First Time programme – or GIRFT – which aims to improve services and make sure people get more consistent care across the whole NHS.
Part of our evaluation involves asking two sets of people –
i) patients over 60 who have had orthopaedic surgery in the last two years and ii) people over 60
about their views on orthopaedic surgery and improving outcomes.
We’re running focus groups in March
People who have had a hip or knee replacement in a NHS hospital within the last two years Aged over 60
21st March – UCL Farr Institute, 222 Euston Road, London, NW1 2DA
The Centre is funded by Barts Charity and based within Queen Mary University of London at the Whitechapel campus.
The centre team (pictured above) will focus on improving the health of mothers and babies in East London, addressing healthcare challenges such as diabetes, obesity and heavy blood loss during childbirth.
The first BARC study is set to start in January 2018 – “EMmY: Effectiveness and acceptability of myo-inositol nutritional supplement in the prevention of gestational diabetes: a pilot placebo controlled double blind randomised trial”.
EmMY will aim to randomise 200 women who are at risk of developing gestational diabetes, across three sites (Barts Health, Guy’s and St Thomas’, and Central Manchester University NHS Trusts).
Participants will be randomised to receive either 4g of Myo-inositol – a naturally occurring substance produced in the human body that belongs to the vitamin B complex group – or placebo study supplement daily, from the end of the first trimester until delivery.
The pilot will examine rates of recruitment and randomisation to the trial, and rates of adherence to the intervention. Researchers will analyse reasons for participation, non-participation, and non-adherence to the trial protocol. Any preliminary estimates and insight into trial procedures from the EMmY study will then inform a future large-scale trial.
The CLAHRC is supporting the study by providing health economic analysis for the pilot and full trial and assisting with patient and public involvement..
CLAHRC North Thames PhD Marissa Mes enjoyed success at the prestigious Annual Scientific Meeting (ASM) of the Asthma UK Centre for Applied Research (AUK CAR).
Marissa won best poster presentation when she showcased her work to delegates during the conference (below) – her research focus is assessing whether pharmacists are a suitable delivery channel for an intervention aimed at asthma patients to improve their adherence to preventer inhalers.
Our congratulations to Marissa on her prize.
Marissa’s fellow CLAHRC PhD Caroline Katzer, who is developing and evaluating an intervention to improve adherence to inhaled corticosteroids (ICS) in adult asthma patients also showcased her work at the conference via both a poster and an oral presentation, which generated a lot of discussion, and was among those complimented on the quality of her presentations.
Both PhDs are funded by the CLAHRC and affiliated to AUKCAR.
Prof. Stephen Stansfeld is Professor of Psychiatry at QMUL. His research involves longitudinal studies of risk and protective factors for mental health in adolescence, life course studies of social and environmental risk factors and intervention studies on work and mental health. He is Co-Principal Investigator of ORiEL Study, a NIHR-funded cluster randomised trial of the impact of the regeneration surrounding the Olympics on children’s wellbeing and physical activity.
Antonio holds a BSc in Psychology and an MSc in Research Methods and Implementation in Psychology and Health, both from the University of Granada, Spain. He has also been awarded a Ph.D. from the University of Granada, for his work in the Andalusian School of Public Health. During this time, he was part of several research projects, mostly focused on health inequalities and health systems, prior to joining UCL. Antonio has particular interest in research methods in health, mostly systematic reviews and meta-analysis.
The end of any year sees a number of “best of” charts published and research is no exception!
We’re delighted to report that a paper produced by the CLAHRC’s Dr Werner Leber and Professor Chris Griffiths and others is 2017’s most downloaded in The Lancet HIV. Dr Werner ‘s groundbreaking work represents the first time a model to explore the cost effectiveness of screening for HIV in primary care has been applied to the UK.
The work generated great media interest (below) and offers a model to measure cost-effectiveness for commissioners and providers of HIV care.
Read the paper:
Cost-effectiveness of screening for HIV in primary care: a health economics modelling analysis
Baggaley, Rebecca F et al.
The Lancet HIV , Volume 4 , Issue 10 , e465 – e474